0001127602-21-010883.txt : 20210316
0001127602-21-010883.hdr.sgml : 20210316
20210316185057
ACCESSION NUMBER: 0001127602-21-010883
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180315
FILED AS OF DATE: 20210316
DATE AS OF CHANGE: 20210316
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BENKOWITZ MICHAEL
CENTRAL INDEX KEY: 0001673232
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 21747640
MAIL ADDRESS:
STREET 1: C/O UNITED THERAPEUTICS CORP
STREET 2: 1040 SPRING STREET
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4/A
1
form4a.xml
PRIMARY DOCUMENT
X0306
4/A
2018-03-15
2021-03-16
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001673232
BENKOWITZ MICHAEL
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
President and COO
Common Stock
2235
D
Stock Options
111.00
2018-03-15
4
A
0
85531
0
A
2021-03-15
2028-03-15
Common Stock
85531
85531
D
Includes 237 shares acquired on March 4, 2021, under the United Therapeutics Corporation Employee Stock Purchase Plan.
These performance-based stock options were initially awarded on March 15, 2018, subject to a three-year performance condition tied to average cash profit margin during 2018-2020, which was determined on February 24, 2021. Number of stock options reported represents the number of options earned based on performance.
This Form 4/A is being filed to correct the expiration date of this award.
/s/ John S. Hess, Jr. under Power of Attorney
2021-03-16